Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis

AIM: To evaluate the efficacy of switching from bevacizumab to ranibizumab or aflibercept in eyes with diabetic macular edema (DME) unresponsive to bevacizumab. METHODS: Single-center retrospective comparative study of patients with DME unresponsive to intravitreal bevacizumab that was switched to ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Pessoa, Bernardete, Malheiro, Luísa, Carneiro, Inês, Monteiro, Sílvia, Coelho, João, Coelho, Constança, Figueira, João, Meireles, Angelina, Melo Beirão, João Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837538/
https://www.ncbi.nlm.nih.gov/pubmed/33519187
http://dx.doi.org/10.2147/OPTH.S280644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837538/
https://www.ncbi.nlm.nih.gov/pubmed/33519187
http://dx.doi.org/10.2147/OPTH.S280644

Ejemplares similares